Kamis, 03 September 2026 - 15:40 WIB

Find and Follow Us

Global Markets

IHSG 6,231.78 +0.00%

S&P 500 7,443.28 -0.19%

NASDAQ 25,508.07 -0.05%

Dow Jones 51,839.26 -0.59%

FTSE 100 10,524.80 -0.71%

CAC 40 8,340.11 +0.02%

Nikkei 225 65,193.75 +1.64%

Hang Seng 25,111.29 -0.13%

Shanghai 3,779.30 -0.45%

KOSPI 6,712.12 +3.01%

STI 5,513.85 +0.27%

ASX 200 8,766.60 -0.28%

Sensex 77,708.52 -0.57%

Gold 4,030.20 +0.44%

Silver 57.26 +2.17%

Oil (WTI) 82.30 -0.23%

Brent 88.63 +0.60%

Copper 6.37 +2.33%

Gas Alam 2.85 -2.27%

Bitcoin 65,194.22 +0.00%

Ethereum 1,906.44 +0.00%

USD/IDR 17,971.00 +0.21%

EUR/USD 1.14 -0.08%

ProSTEM menyelenggarakan uji klinis untuk terapi Retinitis Pigmentosa (RP)

ProSTEM Buka Harapan Baru Bagi Pasien Retinitis Pigmentosa Lewat Uji Klinis Terapi Sel Punca

Redaksi • 28 April 2025

Latest Updates

ProSTEM menyelenggarakan uji klinis untuk terapi Retinitis Pigmentosa (RP)

13:38 WIB • 28 April 2025

ProSTEM Buka Harapan Baru Bagi Pasien Retinitis Pigmentosa Lewat Uji Klinis Terapi Sel Punca

ProSTEM menggelar uji klinis terapi sel punca untuk Retinitis Pigmentosa, menawarkan harapan baru bagi pasien gangguan penglihatan…